Department of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
Mol Med Rep. 2023 Dec;28(6). doi: 10.3892/mmr.2023.13114. Epub 2023 Oct 20.
Sepsis is a manifestation of the immune and inflammatory response to infection, which may lead to multi‑organ failure. Health care advances have improved outcomes in critical illness, but it still remains the leading cause of death. Septic cardiomyopathy is heart dysfunction brought on by sepsis. Septic cardiomyopathy is a common consequence of sepsis and has a mortality rate of up to 70%. There is a lack of understanding of septic cardiomyopathy pathogenesis; knowledge of its pathogenesis and the identification of potential therapeutic targets may reduce the mortality rate of patients with sepsis and lead to clinical improvements. The present review aimed to summarize advances in the pathogenesis of cardiac dysfunction in sepsis, with a focus on mitochondrial dysfunction, metabolic changes and cell death modalities and pathways. The present review summarized diagnostic criteria and outlook for sepsis treatment, with the goal of identifying appropriate treatment methods for this disease.
脓毒症是机体对感染的免疫和炎症反应的一种表现,可能导致多器官功能衰竭。医疗保健的进步改善了危重病患者的预后,但它仍然是主要的死亡原因。脓毒性心肌病是由脓毒症引起的心脏功能障碍。脓毒性心肌病是脓毒症的常见后果,死亡率高达 70%。人们对脓毒性心肌病发病机制的认识不足;了解其发病机制和确定潜在的治疗靶点可能会降低脓毒症患者的死亡率,并带来临床改善。本综述旨在总结脓毒症中心脏功能障碍发病机制的研究进展,重点关注线粒体功能障碍、代谢变化以及细胞死亡方式和途径。本综述总结了脓毒症的诊断标准和治疗前景,旨在为该疾病确定合适的治疗方法。